Core Viewpoint - Aimfinity Investment Corp. I has announced revised terms for its Charter Amendment Proposal in connection with an extraordinary general meeting of shareholders, which has been adjourned to January 9, 2025 [1][2]. Group 1: Meeting Details - The deadline for public shareholders to submit redemption requests has been extended to 5:00 p.m. Eastern Time on January 8, 2025 [3]. - The record date for determining shareholders entitled to vote at the meeting remains November 27, 2024, allowing shareholders who sold their shares after this date to still vote [3]. - The physical location of the extraordinary meeting is confirmed to be in Pingtung City, Taiwan, with virtual attendance available through prior registration [4]. Group 2: Charter Amendment Proposal - If approved, the Company will have until January 28, 2025, to complete a business combination, with the option to extend this deadline up to nine times, each by one month, potentially extending to October 28, 2025 [6]. - The new required contribution to the trust account for each New Monthly Extension is set at $0.05 per remaining public share, compared to the original proposal of $0.033 per share or a total of $15,000 for all remaining shares [6]. - The Company has agreed not to use trust proceeds, including interest earned, to pay for dissolution expenses [6]. Group 3: Proxy and Documentation - A proxy statement was filed with the SEC on December 11, 2024, urging investors to read it carefully for important information regarding the meeting [8]. - Free copies of the proxy statement and other documents can be obtained through the SEC's website or by contacting the proxy solicitor [9].

Company Overview - Aimfinity Investment Corp. I (AIMA) is a special purpose acquisition company incorporated as a Cayman Islands exempted company, focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [14] Proposed Business Combination - On October 13, 2023, AIMA entered into a Merger Agreement with Docter Inc. and its subsidiaries, proposing a business combination involving a reincorporation merger and an acquisition merger [2] - The proposed business combination is subject to the approval of AIMA's stockholders, who will receive a proxy statement/prospectus with important information regarding the transaction [2][8] Extension of Business Combination Deadline - AIMA has extended the deadline to complete its initial business combination from December 28, 2024, to January 28, 2025, by depositing $60,000 into its trust account [13] Future Financial Performance - The press release includes forward-looking statements regarding anticipated future financial and operating performance, including estimates for growth and expected management and governance of the combined company [9][15]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with a target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from November 28, 2024, to December 28, 2024, following a deposit of $60,000 into its trust account [1] - This extension marks the eighth of nine monthly extensions allowed under the company's current charter, which permits monthly extensions until January 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further details regarding the proposed business combination will be provided in a proxy statement/prospectus to be filed with the SEC [4]

IPO and Funding - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[115]. - A private placement generated an additional $4.92 million from the sale of 492,000 units at the same price, totaling net proceeds of $82.11 million deposited in a trust account[115]. - The company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees and $2,817,500 in deferred underwriting fees[140]. - The company issued promissory notes totaling up to $2,500,000 to I-Fa Chang for working capital purposes, which are non-interest bearing and unsecured[144][145][146]. Business Combination - On October 13, 2023, the company entered into a Business Combination Agreement with Docter Inc., which will result in the merger and the company becoming publicly traded[118]. - The Business Combination will involve the issuance of 6 million PubCo Ordinary Shares valued at $60 million, with potential earnout shares contingent on device sales[120][121]. - The company has extended the deadline for consummating an initial business combination to April 28, 2024, with a total of $765,000 deposited for nine one-month extensions[125]. - The second extraordinary general meeting approved further extensions to January 28, 2025, with payments of $60,000 for each one-month extension[126][127]. - The company has entered into a backstop agreement to ensure net tangible assets of at least $5,000,001 upon closing of the Business Combination[135]. Financial Performance - For the three months ended September 30, 2024, the company reported a net income of $24,789, with interest income of $464,528 and operating costs of $439,739[137]. - For the nine months ended September 30, 2024, the company had a net income of $902,163, consisting of interest income of $1,603,118 and operating costs of $700,955[138]. - As of September 30, 2024, the company held $36,327,836 in the Trust Account, which is invested in money market funds and U.S. Treasury Securities[141]. - As of September 30, 2024, the company had cash of $4,895 and a working capital deficiency of $2,972,900[148]. Operational Challenges - The company has reported no revenue since inception and has incurred losses due to formation and operating costs, relying on securities sales and loans for funding[117]. - The company has not generated any operating revenues to date and does not expect to do so until after completing its Initial Business Combination[136]. - Management has raised substantial doubt about the company's ability to continue as a going concern if it cannot complete an Initial Business Combination by the Combination Deadline[149]. - The company anticipates significant costs in pursuing acquisition plans and cannot assure the success of completing the Initial Business Combination[114]. Governance - The board of directors of PubCo will consist of five directors post-merger, with a new composition following an amendment to the Business Combination Agreement[122][124]. - The company has issued unsecured promissory notes for payments made for extensions, with no interest and payable upon the consummation of the initial business combination[128][129]. - The company has no off-balance sheet financing arrangements as of September 30, 2024[150].

IPO and Funding - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[111]. - A total of $82.11 million from the IPO and private placement was deposited in a trust account for the benefit of public shareholders[111]. - The company has incurred losses since inception and currently has no revenue, relying on the sale of securities and loans for funding[113]. - The company has relied on the Sponsor for funding, with promissory notes issued for payments related to extensions[125]. - The company issued a promissory note to I-Fa Chang for up to $500,000 to be used for working capital, which is non-interest bearing and unsecured[138]. - The company has no off-balance sheet financing arrangements as of June 30, 2024[143]. Business Combination - On October 13, 2023, the company entered into a Business Combination Agreement with Docter Inc., which will result in the company being merged into a newly formed subsidiary[114]. - The Business Combination will involve the issuance of 6 million PubCo Ordinary Shares valued at $60 million to the Pre-Closing Target Stockholders[116]. - An additional 2.5 million Earnout Shares may be issued based on sales performance, with 1 million shares contingent on selling at least 30,000 devices in fiscal year 2024[117]. - The company has extended the deadline to consummate an initial business combination to April 28, 2024, with provisions for up to nine one-month extensions[121]. - The company has made three payments of $60,000 each for the Second Charter Amendment Monthly Extensions, extending the deadline to August 28, 2024[123]. - The board of directors of PubCo will consist of five directors post-business combination, with three designated by the Target and two by the Sponsor[120]. Financial Performance - For the three months ended June 30, 2024, the company reported a net income of $438,510, down from $640,387 in the same period of 2023, reflecting a decrease of approximately 31.5%[132]. - For the six months ended June 30, 2024, the company had a net income of $877,374, compared to $1,319,926 for the same period in 2023, indicating a decline of about 33.5%[133]. - As of June 30, 2024, the company held $35,683,308 in the Trust Account, which is invested in money market funds and U.S. Treasury Securities[135]. - The company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees and $2,817,500 in deferred underwriting fees[134]. - As of June 30, 2024, the company had cash of $4,895 and a working capital deficiency of $2,353,161[140]. - The company has not generated any operating revenues to date and does not expect to do so until after completing its Initial Business Combination[131]. - The company has substantial doubt about its ability to continue as a going concern if it cannot complete an Initial Business Combination by the Combination Deadline[142]. Use of Funds - The company intends to use funds held outside the Trust Account primarily for identifying and evaluating target businesses and performing due diligence[136].

IPO and Funding - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit [115]. - A total of $82.11 million from the IPO and private placement was deposited into a trust account for the benefit of public shareholders [115]. - The company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees and $2,817,500 in deferred underwriting fees [143]. - The company issued a promissory note to I-Fa Chang for up to $500,000 for working capital, which is non-interest bearing and unsecured [139]. Business Combination - On October 13, 2023, the company entered into a Business Combination Agreement with Docter Inc., which will result in the company being merged into a publicly traded entity [118]. - The Business Combination will involve the issuance of 6 million PubCo Ordinary Shares, valued at $60 million, to the Pre-Closing Target Stockholders [120]. - An additional 2.5 million Earnout Shares may be issued based on sales performance, with 1 million shares contingent on selling at least 30,000 devices in fiscal year 2024 [121]. - The company plans to continue evaluating acquisition candidates and preparing for the consummation of its initial business combination [117]. Financial Performance - For the three months ended March 31, 2024, the company reported a net income of $438,864, consisting of interest income of $568,384 on investments held in the Trust Account, offset by operating costs of $129,520 [142]. - As of March 31, 2024, the company held $44,618,047 in the Trust Account, which is invested in money market funds and U.S. Treasury Securities [144]. - The company has drawn $816,437 of working capital as of March 31, 2024, with a working capital deficiency of $2,041,465 [150]. - The company has not generated any revenues to date and does not expect to do so until after the completion of its Initial Business Combination [141]. Operational Concerns - The company has incurred losses since inception and currently has no revenue, relying on the sale of securities and loans for funding [117]. - Management has raised substantial doubt about the company's ability to continue as a going concern if it cannot complete an Initial Business Combination by the Combination Deadline [152]. - The company has the right to withdraw interest from the Trust Account to pay taxes, if any [144]. - The company has no off-balance sheet financing arrangements as of March 31, 2024 [153]. - The company has the option to convert working capital loans into Private Placement Units at a conversion price of $10.00 per unit [135]. Extensions and Deadlines - The company has extended its Combination Deadline to April 28, 2024, by depositing $765,000 for nine one-month extensions [122]. - The New MA allows for further extensions up to January 28, 2025, with a reduced monthly extension payment of $60,000 [123]. - As of the report date, 860,884 Public Shares were tendered for redemption, leaving 3,604,998 Class A ordinary shares remaining [125].

IPO and Financial Overview - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[13]. - A total of $82.11 million from the IPO and private placement was deposited in a trust account for the benefit of public shareholders[13]. - Aimfinity completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[115]. - Aimfinity has incurred losses since inception and currently has no revenue, relying on the sale of securities and loans from the sponsor to fund operations[124]. - As of December 31, 2023, Aimfinity had a net income of $1,915,114, consisting of interest income of $3,266,717 on investments held in the Trust Account, offset by operating costs of $1,351,603[143]. - Aimfinity had $43,794,663 held in the Trust Account as of December 31, 2023, which is invested in money market funds and U.S. Treasury Securities[149]. - The Company had a working capital deficiency of $1,656,945 as of December 31, 2023, with $500,000 in borrowings under working capital loans[153]. - Aimfinity has not generated any operating revenues to date and does not expect to do so until after completing its initial business combination[142]. - The Company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees[147]. Business Combination and Strategy - The company focuses on identifying unique business concepts in technology, hospitality, or consumer services sectors, excluding targets headquartered or primarily operating in China[16]. - The company must complete an initial business combination with a total aggregate fair market value of at least 80% of the assets held in the trust account[22]. - The company may pursue initial business combinations jointly with entities affiliated with US Tiger Securities, Inc.[26]. - The company has agreed not to enter into a definitive agreement regarding an initial business combination without prior consent from its sponsor[24]. - The company held an extraordinary general meeting on July 27, 2023, where shareholders approved an extension of the initial business combination period to April 28, 2024, allowing for up to nine one-month extensions[29]. - The company entered into a merger agreement with Docter Inc. on October 13, 2023, which will result in Docter becoming a wholly-owned subsidiary of the company[38]. - The merger consideration includes the issuance of 6,000,000 PubCo Ordinary Shares, valued at $60,000,000, to Docter stockholders[42]. - An additional 2,500,000 PubCo Ordinary Shares may be issued as contingent earnout consideration based on sales performance in fiscal years 2024 and 2025[43]. - The company will provide public shareholders with redemption rights at a per-share price initially anticipated to be $10.20 upon completion of the initial business combination[47]. - The company intends to conduct redemptions in connection with a shareholder vote unless not required by law or if a tender offer is chosen for business reasons[49]. - If shareholder approval is sought, the company will complete the initial business combination only with the affirmative vote of a majority of attending shareholders[51]. - Public shareholders can redeem their shares regardless of their voting decision on the proposed transaction[51]. - A public shareholder is restricted from redeeming more than 15% of the shares sold in the IPO without prior consent, aimed at preventing large block accumulations[52]. - The company has until April 28, 2024, to complete an initial business combination, with the option to extend this period up to January 28, 2025, through additional deposits into the Trust Account[54]. Management and Governance - On March 17, 2023, all directors and officers resigned, and I-Fa Chang was appointed as the sole director and CEO[18]. - The sponsor distributed 280,000 founder shares and 492,000 private placement units to existing members on March 17, 2023[20]. - The company has two executive officers and does not plan to hire full-time employees before completing the initial business combination[66]. - The board of directors consists of five members, with founder shares holders having the right to elect all directors prior to the initial business combination[188]. - The audit committee is composed of independent directors, including Kevin Vassily as Chair, ensuring compliance with Nasdaq listing standards[192]. - The audit committee is responsible for monitoring the independence of the registered public accounting firm and ensuring compliance with applicable laws[193]. - The company has established procedures for handling complaints regarding accounting and internal controls[195]. - No cash compensation has been paid to executive officers or directors prior to the initial business combination, with reimbursements for out-of-pocket expenses being reviewed quarterly[201]. - After the initial business combination, directors may receive consulting or management fees, with full disclosure to shareholders[202]. Risks and Challenges - The company may face risks associated with acquiring financially unstable or early-stage businesses[27]. - The company may face challenges in completing a desirable business combination due to the requirement to finalize it within a prescribed timeframe[72]. - The company may not complete its initial business combination by April 28, 2024, which could result in public shareholders receiving only $10.20 per share or less[74]. - Increased competition among special purpose acquisition companies may lead to higher costs for initial business combinations and difficulty in finding attractive targets[76]. - The ability of public shareholders to redeem shares for cash may deter potential business combination targets, affecting the company's financial attractiveness[70]. - The company may be subject to U.S. foreign investment regulations, which could delay or prohibit the Docter Business Combination[92]. - The Inflation Reduction Act of 2022 imposes a 1% excise tax on stock repurchases, which may affect the company's ability to complete its business combination[86]. - If the Docter Business Combination is subject to CFIUS review, it could significantly impact the timing and feasibility of the transaction[98]. Internal Controls and Reporting - The company is classified as an "emerging growth company," allowing it to take advantage of certain reporting exemptions[60]. - Management assessed the effectiveness of internal controls over financial reporting as of December 31, 2023, and determined that they were not effective due to material weaknesses[177]. - The company has not maintained effective internal control over financial reporting due to inadequate segregation of duties and insufficient written policies and procedures[177]. - The auditor's report for the fiscal year ended December 31, 2022, did not contain an adverse opinion, but expressed uncertainty about the company's ability to continue as a going concern[168]. - The company does not expect its disclosure controls and procedures to prevent all errors or instances of fraud, acknowledging inherent limitations[174]. - There were no changes in internal control over financial reporting that materially affected the company's controls during the reporting period[180]. - Aimfinity has not opted out of the extended transition period for new or revised financial accounting standards, allowing it to adopt changes at the same time as private companies[163]. - The company plans to implement remediation steps to improve internal controls, including enhancing board composition and consulting third-party professionals for complex accounting applications[178]. Shareholder and Ownership Structure - The sponsor currently holds 27.48% of the company's outstanding shares, with significant ownership concentrated among a few individuals[95]. - The initial shareholders beneficially owned approximately 20% of issued and outstanding ordinary shares, allowing them to appoint all directors prior to the initial business combination[209]. - The sponsor has agreed to vote any founder shares and public shares in favor of any proposed business combination and not to redeem any shares in connection with the shareholder vote[210]. - The founder shares and Private Placement Units are subject to transfer restrictions, with initial shareholders agreeing not to transfer their shares until one year after the initial business combination[211]. - I-Fa Chang holds 1,692,500 Class B ordinary shares, representing 84.10% of that class[206]. - Wolverine Asset Management holds 329,567 Class A ordinary shares, representing 7.38% of that class[206]. - Meteora Capital holds 439,851 shares with shared voting and dispositive power[208]. - Xuedong (Tony) Tian, the CFO, holds 100,000 shares, representing 4.97% of Class B ordinary shares[206]. - George Jing Cao holds 280,000 Class B shares (13.91%) and 492,000 Class A shares (6.11%)[206]. - Chun-Cheng Su holds 50,000 Class B shares, representing 2.49% of that class[206]. - The transfer restrictions do not apply to certain permitted transferees, including affiliates and family members of officers or directors[211].

IPO and Business Combination - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[117]. - A total of $82.11 million from the IPO and private placement was deposited into a trust account for the benefit of public shareholders[117]. - On October 13, 2023, the company entered into a Business Combination Agreement with Docter Inc., which will result in the company being merged into a publicly traded entity[120]. - The Business Combination will involve the issuance of 6 million PubCo Ordinary Shares valued at $60 million, with potential additional earnout shares based on future sales performance[122][123]. - The company has extended the period to consummate an Initial Business Combination to April 28, 2024, allowing for up to nine one-month extensions[126][128]. - The company plans to issue up to 2.5 million additional shares as contingent post-closing earnout consideration based on device sales in fiscal years 2024 and 2025[123]. Financial Performance - For the three months ended September 30, 2023, the company reported a net income of $540,850, compared to a net operating loss of $39,529 for the same period in 2022[134]. - The company has incurred significant costs in pursuing acquisition plans and cannot assure the success of its Initial Business Combination[116]. - The company had a working capital deficiency of $894,947 as of September 30, 2023[141]. - The company has not generated any operating revenues to date and does not expect to do so until after the completion of its initial Business Combination[133]. Trust Account and Cash Position - As of September 30, 2023, the company held $42,978,326 in the Trust Account, which is invested in U.S. Treasury Securities[138]. - A total of $82,110,000 was placed in the Trust Account following the IPO and sale of Private Placement Units on April 28, 2022[135]. - The company intends to use funds held in the Trust Account to complete its Business Combination and may withdraw interest to pay taxes[138]. - As of September 30, 2023, the company had cash of $5,503 and no amounts outstanding under any Working Capital Loans[141]. - The company had an aggregate redemption amount of approximately $42,717,717 for 4,076,118 Public Shares redeemed at a price of approximately $10.48 per share[137]. Tax and Accounting - The Company accounts for income taxes under ASC 740, recognizing deferred tax assets and liabilities for expected future tax benefits[157]. - As of September 30, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties[160]. - The Company does not expect the total amount of unrecognized tax benefits to materially change over the next twelve months[161]. - The Company may be subject to potential examination by federal and state taxing authorities regarding income taxes[161]. - Management does not believe that any recently issued accounting standards would have a material effect on the Company's financial statements[162]. Internal Controls - The Chief Executive Officer and General Counsel concluded that the disclosure controls and procedures were not effective as of September 30, 2023[164]. - There has been no change in internal control over financial reporting that has materially affected the Company's internal control during the reporting period[165].

IPO and Financial Overview - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[107]. - The company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees[121]. - The underwriters received a cash underwriting discount of $0.20 per Public Unit, totaling $1,610,000[133]. - For the six months ended June 30, 2023, the company reported a net income of $1,319,926, primarily from interest earned on investments in the Trust Account[120]. Trust Account and Financial Position - As of June 30, 2023, the Trust Account held $84,502,266 in money market funds, primarily invested in U.S. Treasury Securities[122]. - As of June 30, 2023, the company had cash of $5,169 and a working capital deficiency of $242,020[126]. - The company believes it will have sufficient working capital and borrowing capacity to meet its needs through the consummation of a Business Combination or one year from the filing date[127]. - As of June 30, 2023, there were no amounts outstanding under any Working Capital Loans[126]. - The company has no off-balance sheet financing arrangements as of June 30, 2023[129]. Business Operations and Plans - The company has not yet engaged in any operations or generated revenues since its inception on July 26, 2021[119]. - The company plans to use funds held outside the Trust Account primarily for identifying and evaluating target businesses, performing due diligence, and completing a Business Combination[124]. - The company has the option to extend the period to consummate an initial Business Combination up to nine times, each by an additional one-month period, until April 28, 2024[115]. - Up to $1,500,000 of loans may be convertible into units of the post-business combination entity at a price of $10.00 per unit[125]. - The company incurred significant costs in pursuit of financing and acquisition plans and expects to continue doing so[127]. Corporate Governance and Compliance - The company appointed MaloneBailey, LLP as its new independent registered public accounting firm effective April 27, 2023[114]. - All current officers and directors are U.S. citizens, with no significant ties to China, which may impact the search for a Business Combination target[111]. - The Chief Executive Officer and General Counsel concluded that the company's disclosure controls and procedures were not effective as of June 30, 2023[152]. - There has been no change in the internal control over financial reporting that has materially affected the company's internal control during the reporting period[153]. - There are no ongoing legal proceedings against the company[155]. Shareholder Information - As of March 17, 2023, the sponsor held 1,692,500 founder shares after a distribution of 280,000 shares and a repurchase agreement[112]. - On July 27, 2023, 4,076,118 Public Shares were rendered for redemption, resulting in 4,465,882 Class A ordinary shares remaining[116]. - The company accounts for ordinary shares subject to possible redemption at a redemption value of $10.50 per share as of June 30, 2023[138]. - The company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense, with no unrecognized tax benefits as of June 30, 2023[148].

IPO and Financial Overview - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[95]. - The company incurred total transaction costs of $5,117,607 related to the IPO, including $1,610,000 in underwriting fees and $2,817,500 in deferred underwriting fees[103]. - A total of $82,110,000 from the IPO and Private Placement was deposited in a Trust Account for the benefit of public shareholders[95]. Financial Position - As of March 31, 2023, the Trust Account held $83,563,893 in money market funds, primarily invested in U.S. Treasury Securities[104]. - As of March 31, 2023, the company had cash of $5,169 and working capital of $55,966[108]. - The company did not have any cash equivalents as of March 31, 2023[119]. - As of March 31, 2023, the company has no off-balance sheet financing arrangements or obligations[111]. Income and Expenses - For the three months ended March 31, 2023, the company reported a net income of $679,539, primarily from interest earned on investments in the Trust Account, offset by operating costs of $148,492[102]. - The company has incurred and expects to continue incurring significant costs in pursuit of its financing and acquisition plans[109]. Business Operations - The company has not yet engaged in any operations or generated revenues, with expectations to do so only after completing a Business Combination[101]. - The company plans to use funds held outside the Trust Account primarily for identifying and evaluating target businesses and performing due diligence[106]. - The company may need to obtain additional financing to complete its Business Combination or if a significant number of public shares are redeemed[110]. Shareholder Information - The redemption value of ordinary shares subject to possible redemption is $10.38 and $10.28 per share as of March 31, 2023, and December 31, 2022, respectively[120]. Compliance and Controls - The company is classified as an "emerging growth company" and has elected not to opt out of the extended transition period for new accounting standards[116]. - The company’s disclosure controls and procedures were deemed not effective as of March 31, 2023[135]. - There has been no change in internal control over financial reporting that materially affected the company during the reporting period[136]. Legal and Risk Factors - The company is currently not involved in any legal proceedings[138]. - The company has not experienced losses on its cash account and believes it is not exposed to significant credit risks[124]. - There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023[133].